L- (+) -Arabinose

L- (+) -Arabinose inhibits intestinal sucrase activity, thereby reducing sucrose utilization, and consequently decreasing lipogenesis. (In Vitro) :L- (+) -Arabinose is found to be associated with ribose-5-phosphate isomerase deficiency, which is an inborn error of metabolism.L- (+) -Arabinose selectively inhibits intestinal sucrase activity in a noncompetitive manner and suppresses the plasma glucose increase due to sucrose ingestion. (In Vivo) :L- (+) -Arabinose feeding reduced the weights of epididymal adipose tissue in rats. Moreover, plasma insulin and triacylglycerol concentrations were significantly reduced by dietary L- (+) -Arabinose. L- (+) -Arabinose suppresses gluconeogenesis through modulating AMP-activated protein kinase in metabolic disorder mice.